Last $16.83 USD
Change Today -0.08 / -0.47%
Volume 62.8K
HSKA On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 5:20 PM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).

heska corp (HSKA) Snapshot

Open
$17.20
Previous Close
$16.91
Day High
$17.20
Day Low
$16.53
52 Week High
12/18/14 - $17.20
52 Week Low
12/19/13 - $7.76
Market Cap
106.4M
Average Volume 10 Days
39.0K
EPS TTM
$0.48
Shares Outstanding
6.3M
EX-Date
02/25/13
P/E TM
35.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for HESKA CORP (HSKA)

Related News

No related news articles were found.

heska corp (HSKA) Related Businessweek News

No Related Businessweek News Found

heska corp (HSKA) Details

Heska Corporation develops, manufactures, markets, sells, and supports veterinary products for canine and feline companion animal health markets in the United States, Europe, and internationally. The company offers Element DC, DRI-CHEM 7000, and DRI-CHEM 4000 veterinary chemistry analyzers for blood chemistry and electrolyte analysis; HEMATRUE veterinary hematology analyzer to measure white and red blood cell count, platelet count, and hemoglobin levels in animals; Element POC blood gas and electrolyte analyzer; and IV pumps, as well as services and supports HESKA CBC-DIFF veterinary hematology system. It also provides point-of-care heartworm diagnostic test products for dogs and cats; TRI-HEART Plus Chewable Tablets for the prevention of canine heartworm infection, as well as treatment and control of ascarid and hookworm infections; allergy products and services, including ALLERCEPT definitive allergen panels; and veterinary imaging instruments and services, such as digital radiography solutions and ultrasound systems, as well as sells mobile digital radiography products consumable supplies. In addition, the company offers bovine vaccines; biological and pharmaceutical products for other animal health companies; and various turnkey services comprising research, licensing, production, labeling, and packaging, as well as provides validation support and distribution services. Heska Corporation sells its products to veterinarians through a field organization, a telephone sales force, and independent third-party distributors, as well as trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. Heska Corporation was founded in 1988 and is headquartered in Loveland, Colorado.

290 Employees
Last Reported Date: 03/31/14
Founded in 1988

heska corp (HSKA) Top Compensated Officers

Co-Founder and Executive Chairman
Total Annual Compensation: $508.0K
Chief Financial Officer, Executive Vice Presi...
Total Annual Compensation: $289.5K
President of Biologicals & Pharmaceuticals
Total Annual Compensation: $319.8K
Executive Vice President of Product Developme...
Total Annual Compensation: $233.8K
Executive Vice President of Companion Animal ...
Total Annual Compensation: $156.2K
Compensation as of Fiscal Year 2013.

heska corp (HSKA) Key Developments

Heska Corporation Presents at Benchmark's Micro Cap Discovery One-on-One Conference, Dec-11-2014

Heska Corporation Presents at Benchmark's Micro Cap Discovery One-on-One Conference, Dec-11-2014 . Venue: The Palmer House Hilton, 17 E. Monroe, Chicago, IL 60603, United States. Speakers: Robert B. Grieve, Co-Founder and Executive Chairman.

Heska Corporation - Analyst/Investor Day

To discuss opportunities and strategy

Heska Corporation Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended of September 30, 2014

Heska Corporation reported unaudited consolidated earnings results for the third quarter and nine months ended of September 30, 2014. For the quarter, the company reported total net revenue of $21,805,000 compared to $17,595,000 a year ago. Operating income was $341,000 compared to $75,000 a year ago. Income before income taxes was $381,000 compared to loss before income taxes of $18,000 a year ago. Net income was $15,000 compared to net loss of $18,000 a year ago. Net income attributable to the company was $513,000 compared to $241,000 a year ago. Diluted net income per share attributable to the company was $0.08 compared to $0.04 a year ago. For the nine months, the company reported total net revenue of $65,514,000 compared to $54,835,000 a year ago. Operating income was $1,157,000 compared to operating loss of $4,185,000 a year ago. Income before income taxes was $1,188,000 compared to loss before income taxes of $4,319,000 a year ago. Net income was $520,000 compared to net loss of $2,837,000 a year ago. Net income attributable to the company was $1,774,000 compared to net loss attributable to the company of $2,373,000 a year ago. Diluted net income per share attributable to the company was $0.28 compared to diluted net loss per share attributable to the company of $0.41 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HSKA:US $16.83 USD -0.08

HSKA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abaxis Inc $59.73 USD +0.97
Corgenix Medical Corp $0.27 USD +0.004
Hemagen Diagnostics Inc $0.03 USD -0.0003
PetMed Express Inc $14.04 USD +0.14
Trinity Biotech PLC $17.80 USD -0.24
View Industry Companies
 

Industry Analysis

HSKA

Industry Average

Valuation HSKA Industry Range
Price/Earnings 35.5x
Price/Sales 1.1x
Price/Book 2.1x
Price/Cash Flow 36.2x
TEV/Sales 0.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HESKA CORP, please visit www.heska.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.